Canadian Patent

Endovab obtains further granted patent in Canada. The patent relate to a guidewire fixator, a new medical device that enables distal guidewire stability. Many endovascular procedures can benefit from a stable guidewire position, such as peripheral angioplasty as well as f-EVAR and Ch-EVAR.

 “This patent has been approved in several countries worldwide during the last year, and further acceptance is expected. This relates to one of our core technologies and we are pleased to see that the IP is growing as planned” comments Linus Bosaeus, CEO Endovab.



Senaste nyheter